checkAd
    Startseite > Aktien > Verrica Pharmaceuticals > Nachrichten
    Verrica Pharmaceuticals Aktie
    8,5100
     
    USD
    +2,16 %
    +0,1800 USD
    Letzter Kurs 01.06.24 Nasdaq
    8,4900
     
    USD
    100 STK
    Geldkurs 31.05.24
    8,5100
     
    USD
    800 STK
    Briefkurs 31.05.24
    ISIN: US92511W1080 · WKN: A2JPEV · SYM: VRCA · USA

    Neueste Nachrichten

    Verrica Pharmaceuticals to Participate in the Jefferies Global Healthcare Conference in New York
    30.05.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals Announces Amendment to Company’s Collaboration and License Agreement with Torii Pharmaceutical Co. Ltd. to Fund Global Pivotal Phase 3 Clinical Trial to Study YCANTH for the Treatment of Common Warts
    15.05.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals Reports First Quarter 2024 Financial Results
    13.05.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals to Present at Upcoming Investor Conferences
    09.05.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals to Provide a Corporate Update and Report First Quarter 2024 Financial Results on May 13, 2024
    08.05.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals Announces Presentation at the 23rd Annual Needham Virtual Healthcare Conference
    02.04.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals Announces that YCANTH Receives New Chemical Entity Status and Orange Book Listing from the FDA
    26.03.24 · globenewswire · Verrica Pharmaceuticals
    VERRICA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
    09.03.24 · Business Wire (engl.) · Verrica Pharmaceuticals
    Verrica Pharmaceuticals Reports Fourth Quarter and Full-Year 2023 Financial Results
    29.02.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals Announces Participation in the TD Cowen 44th Annual Healthcare Conference
    27.02.24 · globenewswire · Verrica Pharmaceuticals
    Verrica Pharmaceuticals to Provide a Corporate Update and Report Fourth Quarter and Full-Year 2023 Financial Results on February 29, 2024
    22.02.24 · globenewswire · Verrica Pharmaceuticals
    VERRICA PHARMACEUTICALS INVESTIGATION INITIATED by Former Louisiana Attorney General: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Verrica Pharmaceuticals Inc. - VRCA
    14.02.24 · Business Wire (engl.) · Verrica Pharmaceuticals